Related by context. All words. (Click for frequent words.) 60 Squalamine 60 multicenter Phase II 59 lanreotide 59 Phase IIb III 59 intranasal formulation 59 targeted nucleotide prodrug 59 DNA intercalator 59 solubilization 58 humanized monoclonal 58 hypoxia activated prodrug 58 Treanda bendamustine 58 histamine dihydrochloride 58 Factor VIIa 57 AKT inhibitor 57 AERx ® 57 mediated inhibition 57 receptor tyrosine kinase inhibitor 57 fosbretabulin 57 muscarinic antagonist 57 Orally administered 57 bortezomib Velcade 57 degranulation 57 antimitotic 57 Phase Ib clinical 57 haemostatic 57 prostaglandin E1 57 NP2 Enkephalin 57 potent inducer 57 quinoline 57 BioSilicon 57 pentostatin 57 multicenter randomized placebo controlled 57 aurora kinase 57 PEP# [003] 56 protamine sulfate 56 selectively inhibits 56 microtubule inhibitor 56 fibrotic disease 56 Certolizumab pegol 56 parthenolide 56 Phase #b/#a clinical 56 INS# [001] 56 VNP#M 56 nimodipine 56 mesylate 56 Phase Ib II 56 PI3K/Akt pathway inhibitor 56 Onconase 56 covalently linked 56 alkylating agent 56 indibulin 56 phase IIb III 56 generation purine nucleoside 56 delipidation 56 cysteamine bitartrate 56 gamma secretase inhibitor 56 Tolvaptan 56 GSK3B 56 acetonide FA 56 phase Ib clinical 56 Saforis 56 Lixivaptan 55 oral prodrug 55 oral beclomethasone dipropionate 55 malignant ascites 55 buccal spray 55 PDE4 inhibitor 55 prostaglandin synthesis 55 NanoEmulsion 55 Indomethacin 55 homotaurine 55 lignocaine 55 tolevamer 55 CCR1 55 Cotara ® 55 2 methoxyestradiol 55 Exherin TM 55 inverse agonist 55 5 HT2C 55 phase IIa clinical 55 Aplidin 55 trastuzumab DM1 T DM1 55 levoleucovorin 55 treat chronic sinusitis 55 disodium 55 intra tumoral 55 trial evaluating PRX# 55 Temsirolimus 55 ara C 55 PAOD 55 huC# DM4 55 Phase IIb clinical trials 55 Deforolimus 55 JAK inhibitor 55 EVIZON TM 55 SGLT2 inhibitor 55 Cloretazine R 55 aurora kinase inhibitor 55 CHAMPION PCI 55 Replacement Therapy 55 nitric oxide donating prostaglandin 55 DURIN TM 55 peripherally restricted 55 topoisomerase II 55 Phase IIA 55 Vascular Wrap TM 55 ATL# [002] 55 BrachySil ™ 55 Prodarsan R 55 gonadotrophin releasing hormone GnRH 55 pivotal bioequivalence 55 PrevOnco 55 wilate ® 54 CG# [003] 54 Phase #b/#a 54 cardiac repolarization 54 Lauriad ® 54 prokinetic 54 phase IIb clinical 54 GMX# 54 immuno modulatory 54 QLT Plug Delivery 54 Pyridorin 54 REP# 54 CYT# potent vascular disrupting 54 BNC# 54 cyclic peptide 54 topoisomerase II inhibitor 54 inhaled AAT 54 Epirubicin 54 RELOVAIR ™ 54 Kamada AAT 54 PEGylated interferon 54 ELACYT 54 TRPV1 agonist 54 MVA MUC1 IL2 54 plasmid encoding 54 CCR5 inhibitor 54 TEC #OL 54 corticosteroid dexamethasone 54 Cand5 54 KB# [002] 54 2A agonist 54 demonstrated antitumor activity 54 murine model 54 alpha#beta# integrin 54 AGGRASTAT R Injection tirofiban 54 preclinical pharmacokinetic 54 BrachySil TM 54 Microplasmin 54 HDL Selective Delipidation 54 EGS# 54 NeoLipid TM 54 Vidaza azacitidine 54 MGd 54 Panzem ® 54 allogeneic cell 54 Cloretazine 54 acyclovir Lauriad R 54 norfloxacin 54 ursodiol 54 Degarelix 54 vinorelbine tartrate 54 Chemokine Receptor 54 UPLYSO 54 NMDA antagonist 54 lexidronam injection 54 orally administered inhibitor 54 AdhTAP 54 infused intravenously 54 Pafuramidine 54 multidose 54 Phase 1b clinical trials 54 targeted radiotherapeutic 54 Anti VEGF 54 pancrelipase 54 NS3 protease 54 GRNVAC1 54 small molecule tyrosine 54 HuMax TAC 53 paclitaxel poliglumex 53 methylnaltrexone bromide 53 Amoxicillin PULSYS Phase III 53 HDAC Inhibitor 53 Cloretazine ® 53 cathepsin K inhibitor 53 initiated Phase Ib 53 IL# PE#QQR 53 mTOR inhibition 53 novel histone deacetylase 53 RezularTM 53 biliary tract cancer 53 somatostatin analog 53 Oxycyte TM 53 Myolimus 53 Fentanyl TAIFUN R 53 Dacogen decitabine 53 OvaRex ® MAb 53 COPREXA ™ 53 topical gel containing 53 Cholestagel ® 53 Abbokinase 53 Alferon N 53 recurrent glioblastoma multiforme 53 erythropoietic 53 Hedgehog Pathway Inhibitor 53 ToGA 53 Phase 1a clinical 53 recurrent herpes labialis 53 Cytolin 53 sitaxsentan 53 injectable formulations 53 Fondaparinux 53 2A receptor agonist 53 lorvotuzumab mertansine 53 oxypurinol 53 BRIM3 53 astemizole 53 tramiprosate Alzhemed TM 53 TLK# 53 mineralocorticoid 53 acyclovir Lauriad ® 53 parenterally administered 53 urate oxidase 53 vernakalant hydrochloride 53 Trabectedin 53 drug GAP #B# 53 CIMZIA R 53 AOD# [002] 53 angiotensin II receptors 53 chlordiazepoxide 53 PNP inhibitor 53 menadione 53 PrevOnco ™ 53 Ca DTPA 53 SinuNase ™ 53 vascular thrombosis 53 TH# [003] 53 selectively inhibiting 53 AE# vaccine 53 Pathway Inhibitor 53 Triapine R 53 molecular imaging radiopharmaceutical 53 BN# [002] 53 Pharmacokinetic studies 53 fibrotic disorders 53 lipoprotein lipase deficiency LPLD 53 polymerase inhibitor 53 ULTRASE 53 gemcitabine Gemzar ® 53 PS# DARA 53 AlleRx 53 injectable diclofenac 53 phase IIa 53 photodynamic 53 botulinum neurotoxin type 53 CCR5 antagonist 53 overactive bladder AA# 53 treatmentof 53 CytoFabTM 53 candidate TNFerade biologic 53 non nucleoside inhibitor 53 phase Ib 53 BRILINTA 52 Phase 1b clinical 52 thrombolytic agent 52 BETAS 52 transmucosal delivery system 52 aerosolized surfactant 52 blood clot dissolving 52 PhG alpha 1 52 MKC# MKC# PP 52 Cefuroxime 52 Curaxin CBLC# 52 vasodilatory 52 hormone LHRH antagonist 52 Ostabolin C TM 52 Onalta ™ 52 RhuDex ® 52 vascular disrupting 52 Phase IIa Clinical Trial 52 Itraconazole 52 oral methylnaltrexone 52 PEARL SC 52 Pivotal Phase III 52 MAGE A3 ASCI 52 ATL# [001] 52 plasmid DNA pDNA 52 sterile lidocaine patch 52 ERK signaling 52 topical formulations 52 beta. 52 orally disintegrating 52 #I TM# 52 CRMD# 52 novel therapeutic antibodies 52 Nifedipine 52 aminophylline 52 YONDELIS 52 Parathyroid hormone 52 Cytarabine 52 subcutaneous SC 52 Budesonide 52 PDE# inhibitors 52 Irinotecan Hydrochloride Injection 52 cerebral vasospasm 52 CDK inhibitor 52 cannabinor 52 phase IIb trial 52 antimetastatic 52 apricitabine ATC 52 interferon alpha IFN 52 acute mania 52 Aurograb 52 eculizumab therapy 52 Cloretazine VNP#M 52 PPAR gamma agonist 52 potentiation 52 ISTODAX 52 iobenguane 52 EVIZON ™ 52 Intraject 52 histone deacetylase HDAC inhibitor 52 Alvesco ® 52 HDACi 52 LPLD 52 IV Busulfex 52 sodium thiosulfate 52 Phase Ib study 52 alagebrium 52 agent VDA 52 Omacetaxine 52 Zenvia ™ 52 GLP toxicology studies 52 radiation sensitizer 52 Liposomal 52 pyrophosphate 52 maleate 52 mutagenicity 52 Stavzor ™ 52 Phase IIB 52 ONCONASE R 52 balsalazide tablet 52 chondroitin sulphate 52 aerosolized KL4 surfactant 52 Losartan 52 mda 7 52 verteporfin 52 GelSite R 52 naturally occurring amino acid 52 Urocidin 52 using Innocoll proprietary 52 nucleotide analog 52 Immunotherapeutic 52 proteolytic cleavage 52 Cefazolin 52 alemtuzumab MS 52 Completes Patient Enrollment 52 ALK inhibitors 52 Phase III confirmatory 52 Spiegelmer ® 52 Androxal TM 52 NeuroSTAT ® 52 Aclidinium 52 pralidoxime 52 vaso occlusive crisis 52 Pimavanserin 52 DACH platinum 52 synthetic retinoid 52 LEP ETU 52 nonselective NSAID 52 midstage clinical 52 non nucleoside HCV 52 Deferiprone 52 Octreotide 52 NAGS deficiency 52 mesilate 52 IMiDs R 52 cyclic nucleotide 52 cis retinoic acid 52 docetaxel Taxotere ® 52 Hedgehog pathway inhibitor 52 #beta estradiol 51 phase IIIb 51 intravenously administered 51 DXL# 51 Phase III ADT 51 ACTIVE W 51 Cintredekin besudotox 51 Diabetic Macular Edema DME 51 Annexin V 51 preclinical efficacy 51 Etoposide 51 Collategene 51 quaternary ammonium 51 QLT# 51 Aridol TM 51 metastatic malignant 51 TNFerade TM 51 alpha 2A 51 hydrophobic docetaxel prodrug nanoparticle 51 MKC# MT 51 BEZ# 51 estradiol transdermal spray 51 Androgel R 51 pharmaceutically acceptable 51 ThermoDox R 51 topically administered 51 bisulfite 51 bicyclic 51 evaluating satraplatin 51 Cytolin ® 51 LymphoStat B TM 51 serotonin norepinephrine reuptake inhibitor 51 Novolimus 51 brivaracetam 51 Kahalalide F 51 monohydrate 51 H2 antagonists 51 NXC 51 dual orexin receptor 51 Ganciclovir 51 liposome encapsulated 51 SPRIX ® 51 epoetin alpha 51 nitrofurantoin 51 Amphotericin 51 MTP inhibitor 51 TransVax tm 51 DUROS 51 Multaq dronedarone 51 volociximab 51 incyclinide 51 Motesanib 51 Annamycin 51 + enantiomer 51 oxime 51 Phase #b/#a trial 51 oxidative stress inducer 51 PSMA ADC 51 oral ghrelin agonist 51 Benzyl 51 Brostallicin 51 CEQ# 51 Pliaglis 51 injected subcutaneously 51 SIR Spheres 51 inecalcitol 51 Phase III randomized controlled 51 Hedgehog antagonist 51 SinuNase TM 51 hormone agonist 51 Iloperidone 51 pharmacodynamic PD 51 ATIR 51 tiapamil 51 ZYBRESTAT TM 51 hydrochloride capsules 51 Ovidrel 51 iron chelator 51 gonadotrophin 51 Zonisamide 51 interferon beta 1b 51 treat benign prostatic 51 class anticancer quinolone 51 sitagliptin metformin 51 Resten NG 51 PI3K inhibition 51 EXPAREL TM 51 DNA adducts 51 opiate antagonist 51 potent antiproliferative 51 Phase Ia 51 DNA hypermethylation 51 including eniluracil ADH 51 Tyrosine Kinase Inhibitor 51 rotavirus vaccine Rotarix 51 AVN# Phase 51 Antiarrhythmic 51 biotransformation 51 PDE4 inhibitors 51 torezolid 51 keloid scarring 51 huN# DM1 51 octreotide acetate 51 rALLy clinical trial 51 molecular determinants 51 IMPACT DCM 51 systemic hypotension 51 cefprozil 51 EGFR HER2 51 midstage trials 51 riociguat 51 Urocidin TM 51 vaginally administered lidocaine 51 Maxy G# 51 Phase Ib IIa clinical 51 Panzem R NCD 51 dorzolamide 51 sevelamer carbonate 51 TRX1 51 Soliris eculizumab 51 oocyte maturation 51 immunotherapeutic vaccine 51 Pemetrexed 51 Bevasiranib 51 ischemia induced 51 Panzem R 51 delivery polymer matrix 51 Tamsulosin 51 Lupron Depot R 51 Solazed 51 POSIDUR TM 51 AEG# 51 rhIGF-I/rhIGFBP-3 51 Safinamide 51 5 HT2A receptor 51 intravitreal implant 51 hypochlorous acid 51 L Lysine 51 Occlusive Disease 50 CIP TRAMADOL ER 50 Xelox 50 antibiotics erythromycin 50 imexon 50 Fodosine 50 Aurora kinase inhibitor 50 RSD# oral 50 INACTINE TM 50 subcutaneous methylnaltrexone 50 Excellagen TM 50 antifungal therapy 50 Candesartan 50 Cleviprex TM clevidipine 50 adrenergic regulation 50 reslizumab 50 paracetamol acetaminophen 50 mecasermin 50 tumor necrosis 50 Bosutinib 50 maturation inhibitor 50 phase IIb study 50 Akt inhibitor 50 varespladib 50 squalamine 50 Benzoate 50 mitochondrial pathway 50 Aganocide 50 PFO migraine 50 adipogenic 50 antidepressants SSRIs 50 Phase IIIB IV 50 Atrigel 50 ciprofloxacin hydrochloride 50 bolus injection 50 IMA# 50 PANVAC VF 50 chelator 50 alpha 2A adrenoceptor 50 Serological 50 kinase inhibition 50 Prandin ® 50 Generex Oral lyn tm 50 TBC# 50 Alfacell proprietary ribonuclease 50 mercaptopurine 50 immunotherapeutic agent 50 Shigamabs ® 50 Disulfiram 50 humanized monoclonal antibodies 50 Phase #/#a 50 Preclinical studies suggest 50 novel synthetic peptide 50 EDEMA3 trial 50 DDP# 50 DEEP AF 50 Proxinium TM 50 HGS ETR2 50 ALVESCO ® 50 cervicovaginal 50 extensively metabolized 50 Teysuno 50 small interfering ribonucleic 50 Personalized Immunotherapy 50 Suprax R 50 HepeX B 50 Taxotere docetaxel 50 antibody MAb 50 genomic biomarker 50 herpes zoster shingles 50 Intravenous Infusion 50 octreotide implant 50 Parathyroid Hormone 50 Fibrin Pad 50 GLP1 agonist 50 pamoate 50 pharmacokinetic studies 50 rEV# 50 BioNumerik 50 Mirapexin 50 Intravitreal 50 Achieves Primary Endpoint 50 Sevelamer 50 retaspimycin 50 LPA1 receptor 50 factor Xa inhibitor 50 R#/MEM 50 ARIKACE ™ 50 sildenafil citrate Viagra 50 Colesevelam 50 intra nasal 50 evaluating Actimmune 50 hammerhead ribozyme 50 DermaVir Patch 50 IMiDs ® compound 50 analgesic effects 50 Phase IIIb clinical 50 romazarit 50 Phase Ib IIa 50 MKC# 50 Ursodiol 50 triterpenoids 50 pafuramidine maleate 50 PF # [002] 50 reinitiation 50 Zarnestra 50 Aranesp darbepoetin alfa 50 tumorigenicity 50 Trovax 50 CELVAPAN H#N# 50 idiopathic thrombocytopenic purpura ITP 50 Hepatotoxicity 50 FRAGMIN 50 VersaFilm 50 Proquin XR 50 Sphingomab TM 50 Tyzeka Sebivo 50 telomerase inhibitor drug 50 cetyl 50 ZEVALIN ® 50 BN# [004] 50 DigiFab 50 patientswith 50 NV1FGF 50 induced neurotoxicity 50 alvespimycin 50 OVATURE 50 catheter occlusion 50 BRIM2 50 cefdinir 50 Poly ICLC 50 thorough QT 50 Desmopressin 50 Interferon beta 50 chemokine receptor 50 leukocyte adhesion 50 IAP inhibitor 50 lysyl oxidase 50 vidofludimus 50 Ceplene TM 50 chronic thromboembolic pulmonary 50 naltrexone hydrochloride 50 VITAL Trial 50 TransMID 50 aminobutyric acid 50 microtubule dynamics 50 antiangiogenic 50 selectively inhibited 50 Photodynamic therapy 50 hydroxypropyl 50 novel VDA molecule 50 forodesine 50 Selective Electrochemical Tumor Ablation 50 VEGF receptor inhibitor 50 Hedgehog agonist 50 OMP #R# 50 DSMB recommended 50 MIST II 50 Alfimeprase 50 L proline 50 AGGRASTAT R tirofiban hydrochloride 50 BrachySil 50 im peramivir 50 Gemzar gemcitabine 50 quinapril 50 interferon gamma 1b 50 recurrent glioblastoma multiforme GBM 50 Myocet 50 lenalidomide dexamethasone 50 2DG 50 delayed gastric emptying 50 oligomerization 49 targeting PCSK9 49 surgical adhesions 49 Edoxaban 49 glycoprotein IIb IIIa inhibitor 49 Gentamicin Surgical Implant 49 muscarinic 49 ferric citrate 49 autophagic cell death 49 Bicifadine 49 TELINTRA R 49 duloxetine hydrochloride 49 liquid chromatographic 49 oral salmon calcitonin 49 SNS# T 49 reserpine 49 sodium thiosulfate STS 49 Vicinium TM 49 chelating agent 49 coadministration 49 iii GTx 49 zoledronic acid Zometa 49 PCK# 49 cilengitide 49 Arzerra TM 49 NMDA N 49 glucosamine HCl 49 thetreatment 49 dendritic cell vaccine 49 mitotic kinesin 49 Rylomine TM 49 Phase III Pivotal 49 AERx iDMS 49 valerate 49 outlicensing 49 phase III isavuconazole 49 Mycograb 49 glucokinase activator 49 weekly subcutaneous injections 49 PI3K Akt 49 rThrombin 49 Crizotinib 49 hyoscyamine 49 nalbuphine ER 49 polycythemia vera essential thrombocythemia 49 Phase 2a clinical trials 49 blinded randomized placebo controlled 49 punctal plug delivery 49 N acetyl 49 dual endothelin receptor antagonist 49 Dalbavancin 49 Cytoxan ® 49 Insulin PH# 49 preclinically 49 niacin Tablets 49 INxin 49 OvaRex R 49 Boehringer Ingleheim 49 doxorubicin Transdrug R 49 dipeptide 49 metastatic bladder 49 Circadin R 49 MVA BN 49 edifoligide 49 receptor subunits 49 Bezielle 49 alpha antagonist 49 choroidal vasculopathy 49 HCV polymerase 49 hoFH 49 HPPD 49 RhuDex R 49 Atrasentan 49 bisulfate 49 SPRYCEL ® 49 ™ pralatrexate injection 49 enzyme inhibitor 49 highly bioavailable 49 besylate 49 TRISENOX ® 49 eniluracil 49 Glypromate 49 rosiglitazone maleate 49 Guaifenesin 49 SEPET TM 49 tramiprosate ALZHEMED TM 49 OXi# 49 Denufosol 49 Initiate Clinical Trial 49 neuronal dysfunction 49 gabapentin Neurontin 49 complement inhibitor eculizumab 49 Fibrin Sealant Human 49 TheraCIM h R3 49 clavulanic acid 49 orally inhaled migraine 49 Zemplar Capsules 49 lomitapide 49 NPC 1C 49 isavuconazole 49 EGRIFTA 49 renal kidney 49 recombinant FSH 49 Enhanze Technology 49 recurrent malignant glioma 49 evaluating CK # 49 poststroke depression 49 ON #.Na 49 intradermal injection 49 GVAX ® 49 D3 receptors 49 surgically resected 49 TransVax ™ 49 CBLC# 49 RiVax ™ 49 relapsing remitting MS RRMS 49 Genasense ® oblimersen 49 motesanib diphosphate 49 AZX# 49 KIACTA ™ 49 HuMax EGFr 49 metastatic neuroendocrine tumors 49 inverse agonists 49 Potassium Chloride 49 vecuronium 49 SNT MC# 49 zinc cysteine 49 TELINTRA 49 GLPG# 49 inhalational 49 DHPLC 49 Phase 2a Clinical Trial 49 DepoCyt 49 MIVI III 49 platelet adhesion 49 calcium hydroxylapatite 49 Fosphenytoin 49 Epratuzumab 49 Lenocta 49 Aggrenox R 49 Archexin 49 Initiate Phase II 49 Angiox ® 49 GABA aminotransferase 49 macitentan 49 basal insulin analogue 49 Shire BioChem Inc. 49 allergic airway inflammation 49 TOCOSOL Camptothecin 49 herpetic keratitis 49 samalizumab 49 HDAC3 49 Hyalgan 49 beclomethasone dipropionate BDP 49 Phenytoin 49 JAK3 inhibitor 49 enzymatic hydrolysis 49 rabeprazole sodium 49 Almorexant 49 faropenem medoxomil 49 pediatric pontine glioma 49 gamma aminobutyric acid 49 intravenous iv 49 dose dependently 49 Zn DTPA 49 Mesafem 49 Helicobacter pylori eradication 49 5mg dose 49 oral rivaroxaban 49 luteinizing hormone releasing 49 Ampakine compounds 49 unfractionated heparin UFH 49 PEGylated Fab fragment 49 Hematide ™ peginesatide 49 Evista raloxifene 49 Nanobody 49 visilizumab 49 Phase 2a trial 49 HIV integrase inhibitors 49 VP# [004] 49 Prosaptide 49 Codeine Phosphate 49 Viracept nelfinavir 49 Clolar ® 49 Tasimelteon 49 StemEx 48 Phase 2b kidney transplant 48 JUVISTA R Human 48 BYSTOLIC 48 tungstate 48 Glufosfamide 48 interstitial fibrosis 48 PPAR agonist 48 γ secretase 48 benzyl alcohol 48 calcium phosphate cement 48 recurrent metastatic 48 buccal tablet 48 megestrol acetate 48 torsemide ER 48 Imatinib Mesylate 48 pretransplant 48 Myoblast 48 HQK 48 MyoCell SDF 1 48 Viprinex TM 48 methylnaltrexone 48 Somatuline R Autogel R 48 Tykerb lapatinib 48 epoprostenol 48 Bifeprunox 48 soy isoflavone 48 Vorapaxar 48 Raptiva efalizumab 48 TransVax 48 sodium phosphate 48 cisplatin resistant 48 Troxatyl TM 48 Nasdaq PGNX today 48 Zavesca R 48 Specifid 48 thymidylate synthase TS 48 DEB# 48 goserelin 48 atypical hemolytic uremic syndrome 48 RhuDex TM 48 Vectibix panitumumab 48 HGS ETR1 mapatumumab 48 dicarboxylic acid 48 exploratory Phase IIa 48 GnRH antagonists 48 Uricase PEG 48 valopicitabine NM# 48 LOMUCIN TM 48 cervical ripening 48 OLpur TM H2H 48 cholestyramine 48 renoprotective 48 Tarceva TM 48 cAMP signaling 48 Ecallantide 48 oral talactoferrin 48 RISPERDAL ® 48 IMPACT DCM clinical 48 Drug Candidate 48 Isordil 48 Factor NGF 48 Alzhemed TM 48 acute peripheral arterial 48 Efficacy Trial 48 PRECISE trial 48 Dose Ranging Study 48 confirmatory clinical 48 personalized cellular immunotherapy 48 generation antisense inhibitor 48 omacetaxine mepesuccinate 48 Pagoclone 48 hyaluronic 48 Vascugel ® 48 Phase lll 48 SomatoKine 48 antispasmodic 48 OrCel ® 48 Inhalation Aerosol 48 vivo toxicology 48 Besivance 48 zotarolimus 48 stearate 48 Acute Decompensated Heart Failure 48 BLP# Liposome Vaccine 48 lesional 48 arbaclofen 48 oral PTH 48 Ad5FGF 4 48 INSPIRE Trial Phase III 48 Phase IIIb 48 acid EDTA 48 e2 Collector 48 Shigamabs 48 investigational monoclonal antibody 48 nucleoside tide 48 Investigational Treatment 48 Traficet EN 48 medically refractory 48 Phase Ib 48 MEND CABG 48 CALGB # [002] 48 thiopurine 48 BCR ABL inhibitor 48 Phase III Clinical Trials 48 candidate XP# 48 SCENESSE ® 48 pleiotropic 48 OROS R 48 Elagolix 48 tenascin 48 Cloretazine R VNP#M 48 bevasiranib 48 Fibroblast Growth Factor 48 Phase 2a preventative 48 ACCLAIM II 48 BLA filing 48 carcinoma HCC 48 fostamatinib 48 GOUT 48 myeloproliferative diseases 48 treatment naive genotype 48 BeneFIX